Opening Keynote Panel Discussion: What’s Next in Dermatology Drug Development?

Time: 9:00 am
day: Day One

Details:

• Establishing the current landscape and state-of-the art in dermatology drug development – latest advances and challenges
• Lessons learned for rational and effective drug development in dermatology – discussing a ‘blueprint’ of what success looks like in dermatology drug development
• Analysing the end-to-end pain points that accompany dermatology programs – from improving preclinical translation, to tackling late regulatory and commercial challenges
• Where’s dermatology going? – new indication, new targets, the next antibodies
• Identifying and addressing unmet needs – defining the strategic driver for companies involved in drug development for rare and orphan dermatological diseases or moderate skin conditions (vs. standard of care)
• Driving precision medicine approaches in dermatology

Speakers: